Advertisement

Index by Author

September 1986; 35 (9)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Aoki, T T

    • Plasma level of 13,14-dihydro-15-keto-PGE2 in patients with diabetic ketoacidosis and in normal fasting subjects. Diabetes September 1986 35:1004-1010; doi:10.2337/diabetes.35.9.1004

  2. Axelrod, L

    • Plasma level of 13,14-dihydro-15-keto-PGE2 in patients with diabetic ketoacidosis and in normal fasting subjects. Diabetes September 1986 35:1004-1010; doi:10.2337/diabetes.35.9.1004

B

  1. Babischkin, J

    • Further evidence implicating diacylglycerol generation and protein kinase C activation in agonist-induced increases in glucose uptake. Insulin-like effects of phenylephrine in BC3H-1 myocytes. Diabetes September 1986 35:951-957; doi:10.2337/diabetes.35.9.951

  2. Benjamin, D C

    • Prevention of diabetes in BB rats. I. Evidence suggesting a requirement for mature T cells in bone marrow inoculum of neonatally injected rats. Diabetes September 1986 35:1034-1040; doi:10.2337/diabetes.35.9.1034

  3. Bihoreau, M T

    • Impaired glucose homeostasis in adult rats from hyperglycemic mothers. Diabetes September 1986 35:979-984; doi:10.2337/diabetes.35.9.979

  4. Blackshear, P J

    • Plasma level of 13,14-dihydro-15-keto-PGE2 in patients with diabetic ketoacidosis and in normal fasting subjects. Diabetes September 1986 35:1004-1010; doi:10.2337/diabetes.35.9.1004

  5. Blas, S D

    • Differential activities of tolbutamide, tolazamide, and glyburide in vitro on rabbit myocardial membrane Ca2+-transporting ATPase activity. Diabetes September 1986 35:1044-1048; doi:10.2337/diabetes.35.9.1044

  6. Bolaffi, J L

    • Progressive damage of cultured pancreatic islets after single early exposure to streptozocin. Diabetes September 1986 35:1027-1033; doi:10.2337/diabetes.35.9.1027

  7. Bornstein, W

    • Plasma level of 13,14-dihydro-15-keto-PGE2 in patients with diabetic ketoacidosis and in normal fasting subjects. Diabetes September 1986 35:1004-1010; doi:10.2337/diabetes.35.9.1004

  8. Brosnan, J T

    • Diabetes increases active fraction of branched-chain 2-oxoacid dehydrogenase in rat brain. Diabetes September 1986 35:1041-1043; doi:10.2337/diabetes.35.9.1041

  9. Brosnan, M E

    • Diabetes increases active fraction of branched-chain 2-oxoacid dehydrogenase in rat brain. Diabetes September 1986 35:1041-1043; doi:10.2337/diabetes.35.9.1041

  10. Brownlee, M

    • Trapped immunoglobulins on peripheral nerve myelin from patients with diabetes mellitus. Diabetes September 1986 35:999-1003; doi:10.2337/diabetes.35.9.999

C

  1. Capron, L

    • Growth-promoting effects of diabetes and insulin on arteries. An in vivo study of rat aorta. Diabetes September 1986 35:973-978; doi:10.2337/diabetes.35.9.973

  2. Cerami, A

    • Trapped immunoglobulins on peripheral nerve myelin from patients with diabetes mellitus. Diabetes September 1986 35:999-1003; doi:10.2337/diabetes.35.9.999

  3. Ciboddo, G F

    • Impairment of lymphocyte-suppressive system in recent-onset insulin-dependent diabetes mellitus. Correlation with metabolic control. Diabetes September 1986 35:1053-1057; doi:10.2337/diabetes.35.9.1053

  4. Connolly, M E

    • Effects of fetal insulin secretory deficiency on metabolism in fetal lamb. Diabetes September 1986 35:964-972; doi:10.2337/diabetes.35.9.964

  5. Cooper, D R

    • Further evidence implicating diacylglycerol generation and protein kinase C activation in agonist-induced increases in glucose uptake. Insulin-like effects of phenylephrine in BC3H-1 myocytes. Diabetes September 1986 35:951-957; doi:10.2337/diabetes.35.9.951

  6. Corbo, L M

    • Insulin-receptor development in normal and diabetic pregnancies. Role of membrane fluidity. Diabetes September 1986 35:1020-1026; doi:10.2337/diabetes.35.9.1020

  7. Crosti, F

    • Impairment of lymphocyte-suppressive system in recent-onset insulin-dependent diabetes mellitus. Correlation with metabolic control. Diabetes September 1986 35:1053-1057; doi:10.2337/diabetes.35.9.1053

  8. Cruz, L

    • Progressive damage of cultured pancreatic islets after single early exposure to streptozocin. Diabetes September 1986 35:1027-1033; doi:10.2337/diabetes.35.9.1027

  9. Curnow, R T

    • Prevention of diabetes in BB rats. I. Evidence suggesting a requirement for mature T cells in bone marrow inoculum of neonatally injected rats. Diabetes September 1986 35:1034-1040; doi:10.2337/diabetes.35.9.1034

D

  1. Daniels, F X

    • Effects of nephron loss on glomerular hemodynamics and morphology in diabetic rats. Diabetes September 1986 35:1011-1015; doi:10.2337/diabetes.35.9.1011

  2. Davis, F B

    • Differential activities of tolbutamide, tolazamide, and glyburide in vitro on rabbit myocardial membrane Ca2+-transporting ATPase activity. Diabetes September 1986 35:1044-1048; doi:10.2337/diabetes.35.9.1044

  3. Davis, J S

    • Further evidence implicating diacylglycerol generation and protein kinase C activation in agonist-induced increases in glucose uptake. Insulin-like effects of phenylephrine in BC3H-1 myocytes. Diabetes September 1986 35:951-957; doi:10.2337/diabetes.35.9.951

  4. Davis, P J

    • Differential activities of tolbutamide, tolazamide, and glyburide in vitro on rabbit myocardial membrane Ca2+-transporting ATPase activity. Diabetes September 1986 35:1044-1048; doi:10.2337/diabetes.35.9.1044

E

  1. Engelhard, V H

    • Prevention of diabetes in BB rats. I. Evidence suggesting a requirement for mature T cells in bone marrow inoculum of neonatally injected rats. Diabetes September 1986 35:1034-1040; doi:10.2337/diabetes.35.9.1034

F

  1. Falqui, L

    • Impairment of lymphocyte-suppressive system in recent-onset insulin-dependent diabetes mellitus. Correlation with metabolic control. Diabetes September 1986 35:1053-1057; doi:10.2337/diabetes.35.9.1053

  2. Farese, R V

    • Further evidence implicating diacylglycerol generation and protein kinase C activation in agonist-induced increases in glucose uptake. Insulin-like effects of phenylephrine in BC3H-1 myocytes. Diabetes September 1986 35:951-957; doi:10.2337/diabetes.35.9.951

  3. Ferrero, E

    • Impairment of lymphocyte-suppressive system in recent-onset insulin-dependent diabetes mellitus. Correlation with metabolic control. Diabetes September 1986 35:1053-1057; doi:10.2337/diabetes.35.9.1053

G

  1. Ginsberg-Fellner, F

    • Excess of DR3/4 in type I diabetes. What does it portend? Diabetes September 1986 35:985-989; doi:10.2337/diabetes.35.9.985

  2. Grodsky, G M

    • Progressive damage of cultured pancreatic islets after single early exposure to streptozocin. Diabetes September 1986 35:1027-1033; doi:10.2337/diabetes.35.9.1027

  3. Grunnet, M L

    • Effects of fetal insulin secretory deficiency on metabolism in fetal lamb. Diabetes September 1986 35:964-972; doi:10.2337/diabetes.35.9.964

H

  1. Henry, R R

    • Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus. Diabetes September 1986 35:990-998; doi:10.2337/diabetes.35.9.990

  2. Housset, E

    • Growth-promoting effects of diabetes and insulin on arteries. An in vivo study of rat aorta. Diabetes September 1986 35:973-978; doi:10.2337/diabetes.35.9.973

I

  1. Inverardi, L

    • Impairment of lymphocyte-suppressive system in recent-onset insulin-dependent diabetes mellitus. Correlation with metabolic control. Diabetes September 1986 35:1053-1057; doi:10.2337/diabetes.35.9.1053

J

  1. Jarnet, J

    • Growth-promoting effects of diabetes and insulin on arteries. An in vivo study of rat aorta. Diabetes September 1986 35:973-978; doi:10.2337/diabetes.35.9.973

K

  1. Kasiske, B L

    • Effects of nephron loss on glomerular hemodynamics and morphology in diabetic rats. Diabetes September 1986 35:1011-1015; doi:10.2337/diabetes.35.9.1011

  2. Kazandjian, S

    • Growth-promoting effects of diabetes and insulin on arteries. An in vivo study of rat aorta. Diabetes September 1986 35:973-978; doi:10.2337/diabetes.35.9.973

  3. Keane, W F

    • Effects of nephron loss on glomerular hemodynamics and morphology in diabetic rats. Diabetes September 1986 35:1011-1015; doi:10.2337/diabetes.35.9.1011

  4. Kinebanyan, M F

    • Impaired glucose homeostasis in adult rats from hyperglycemic mothers. Diabetes September 1986 35:979-984; doi:10.2337/diabetes.35.9.979

  5. Ktorza, A

    • Impaired glucose homeostasis in adult rats from hyperglycemic mothers. Diabetes September 1986 35:979-984; doi:10.2337/diabetes.35.9.979

L

  1. Louis, E J

    • Three-allele synergistic mixed model for insulin-dependent diabetes mellitus. Diabetes September 1986 35:958-963; doi:10.2337/diabetes.35.9.958

  2. Lowry, A

    • Diabetes increases active fraction of branched-chain 2-oxoacid dehydrogenase in rat brain. Diabetes September 1986 35:1041-1043; doi:10.2337/diabetes.35.9.1041

M

  1. Mandrup-Poulsen, T

    • Direct effects of cyclosporin A on human pancreatic beta-cells. Diabetes September 1986 35:1049-1052; doi:10.2337/diabetes.35.9.1049

  2. Mylotte, K M

    • Differential activities of tolbutamide, tolazamide, and glyburide in vitro on rabbit myocardial membrane Ca2+-transporting ATPase activity. Diabetes September 1986 35:1044-1048; doi:10.2337/diabetes.35.9.1044

N

  1. Nerup, J

    • Direct effects of cyclosporin A on human pancreatic beta-cells. Diabetes September 1986 35:1049-1052; doi:10.2337/diabetes.35.9.1049

  2. Neufeld, N D

    • Insulin-receptor development in normal and diabetic pregnancies. Role of membrane fluidity. Diabetes September 1986 35:1020-1026; doi:10.2337/diabetes.35.9.1020

  3. Nielsen, J H

    • Direct effects of cyclosporin A on human pancreatic beta-cells. Diabetes September 1986 35:1049-1052; doi:10.2337/diabetes.35.9.1049

  4. Nowlain, R E

    • Progressive damage of cultured pancreatic islets after single early exposure to streptozocin. Diabetes September 1986 35:1027-1033; doi:10.2337/diabetes.35.9.1027

  5. Nukada, H

    • Increased susceptibility to ischemic damage in streptozocin-diabetic nerve. Diabetes September 1986 35:1058-1061; doi:10.2337/diabetes.35.9.1058

O

  1. O'Donnell, M P

    • Effects of nephron loss on glomerular hemodynamics and morphology in diabetic rats. Diabetes September 1986 35:1011-1015; doi:10.2337/diabetes.35.9.1011

  2. Olefsky, J M

    • Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus. Diabetes September 1986 35:990-998; doi:10.2337/diabetes.35.9.990

P

  1. Pavoni, D

    • Impairment of lymphocyte-suppressive system in recent-onset insulin-dependent diabetes mellitus. Correlation with metabolic control. Diabetes September 1986 35:1053-1057; doi:10.2337/diabetes.35.9.1053

  2. Philipps, A F

    • Effects of fetal insulin secretory deficiency on metabolism in fetal lamb. Diabetes September 1986 35:964-972; doi:10.2337/diabetes.35.9.964

  3. Picon, L

    • Impaired glucose homeostasis in adult rats from hyperglycemic mothers. Diabetes September 1986 35:979-984; doi:10.2337/diabetes.35.9.979

  4. Pollet, R J

    • Further evidence implicating diacylglycerol generation and protein kinase C activation in agonist-induced increases in glucose uptake. Insulin-like effects of phenylephrine in BC3H-1 myocytes. Diabetes September 1986 35:951-957; doi:10.2337/diabetes.35.9.951

  5. Pontiroli, A E

    • Impairment of lymphocyte-suppressive system in recent-onset insulin-dependent diabetes mellitus. Correlation with metabolic control. Diabetes September 1986 35:1053-1057; doi:10.2337/diabetes.35.9.1053

  6. Porte, P J

    • Effects of fetal insulin secretory deficiency on metabolism in fetal lamb. Diabetes September 1986 35:964-972; doi:10.2337/diabetes.35.9.964

  7. Protti, P

    • Impairment of lymphocyte-suppressive system in recent-onset insulin-dependent diabetes mellitus. Correlation with metabolic control. Diabetes September 1986 35:1053-1057; doi:10.2337/diabetes.35.9.1053

R

  1. Raye, J R

    • Effects of fetal insulin secretory deficiency on metabolism in fetal lamb. Diabetes September 1986 35:964-972; doi:10.2337/diabetes.35.9.964

  2. Robertson, R P

    • Cyclosporin-induced inhibition of insulin secretion in isolated rat islets and HIT cells. Diabetes September 1986 35:1016-1019; doi:10.2337/diabetes.35.9.1016

  3. Rosenkrantz, T S

    • Effects of fetal insulin secretory deficiency on metabolism in fetal lamb. Diabetes September 1986 35:964-972; doi:10.2337/diabetes.35.9.964

  4. Rosic, N

    • Further evidence implicating diacylglycerol generation and protein kinase C activation in agonist-induced increases in glucose uptake. Insulin-like effects of phenylephrine in BC3H-1 myocytes. Diabetes September 1986 35:951-957; doi:10.2337/diabetes.35.9.951

  5. Roussell, A M

    • Plasma level of 13,14-dihydro-15-keto-PGE2 in patients with diabetic ketoacidosis and in normal fasting subjects. Diabetes September 1986 35:1004-1010; doi:10.2337/diabetes.35.9.1004

  6. Rubinstein, P

    • Excess of DR3/4 in type I diabetes. What does it portend? Diabetes September 1986 35:985-989; doi:10.2337/diabetes.35.9.985

  7. Rugarli, C

    • Impairment of lymphocyte-suppressive system in recent-onset insulin-dependent diabetes mellitus. Correlation with metabolic control. Diabetes September 1986 35:1053-1057; doi:10.2337/diabetes.35.9.1053

S

  1. Scott, J

    • Prevention of diabetes in BB rats. I. Evidence suggesting a requirement for mature T cells in bone marrow inoculum of neonatally injected rats. Diabetes September 1986 35:1034-1040; doi:10.2337/diabetes.35.9.1034

  2. Secchi, A

    • Impairment of lymphocyte-suppressive system in recent-onset insulin-dependent diabetes mellitus. Correlation with metabolic control. Diabetes September 1986 35:1053-1057; doi:10.2337/diabetes.35.9.1053

  3. Shulman, G I

    • Plasma level of 13,14-dihydro-15-keto-PGE2 in patients with diabetic ketoacidosis and in normal fasting subjects. Diabetes September 1986 35:1004-1010; doi:10.2337/diabetes.35.9.1004

  4. Standaert, M

    • Further evidence implicating diacylglycerol generation and protein kinase C activation in agonist-induced increases in glucose uptake. Insulin-like effects of phenylephrine in BC3H-1 myocytes. Diabetes September 1986 35:951-957; doi:10.2337/diabetes.35.9.951

T

  1. Thomson, G

    • Three-allele synergistic mixed model for insulin-dependent diabetes mellitus. Diabetes September 1986 35:958-963; doi:10.2337/diabetes.35.9.958

V

  1. Vlassara, H

    • Trapped immunoglobulins on peripheral nerve myelin from patients with diabetes mellitus. Diabetes September 1986 35:999-1003; doi:10.2337/diabetes.35.9.999

W

  1. Walker, M

    • Excess of DR3/4 in type I diabetes. What does it portend? Diabetes September 1986 35:985-989; doi:10.2337/diabetes.35.9.985

  2. Wallace, P

    • Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus. Diabetes September 1986 35:990-998; doi:10.2337/diabetes.35.9.990

  3. Warnick, P R

    • Differential activities of tolbutamide, tolazamide, and glyburide in vitro on rabbit myocardial membrane Ca2+-transporting ATPase activity. Diabetes September 1986 35:1044-1048; doi:10.2337/diabetes.35.9.1044

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement